DeVeau Michael sold $755K of IFF

International Flavors & Fragrances (IFF) reported Q2 2026 sales of US$1,954 million and net income of US$50 million, with full-year guidance updated for discontinued operations. The company also authorized a new US$2.5 billion share repurchase and reaffirmed its quarterly dividend. The article links the buyback and portfolio reshaping to IFF’s risk and cash-generation outlook.

International Flavors & Fragrances (IFF) shares rose 0.8% in pre-open trading. The company said it will sell its Food Ingredients business to CVC Capital Partners for about $4.3 billion, expected to close by end of Q2 2027, and announced a $2.5 billion share repurchase. Q2 adjusted EPS was $0.82 vs $1.09 expected, revenue $1.95B vs $2.68B, but core results improved. Oppenheimer raised its IFF price target to $95 from $90.

International Flavors & Fragrances (IFF) shares rose 8.9% to $88.07 after its Q2 release. The company reported continuing-operations revenue of $1.954B and adjusted EBITDA of about $408M, with management citing cleaner earnings quality and ~6% growth in both. IFF also updated 2026 guidance for 2% to 4% sales growth and 4% to 8% EBITDA growth.

International Flavors & Fragrances (IFF) shares rose about 9% after Q2 results missed estimates and the company cut full-year revenue guidance by nearly 30% to a midpoint of $7.5 billion. Q2 revenue was $1.95 billion, 25% below expectations, with adjusted EPS of $0.82. Investors focused on 6% organic growth and a higher gross margin.

International Flavors & Fragrances (IFF) shares rose 8.4% to $87.67 on Wednesday after the company announced a $2.5 billion stock buyback, despite a second-quarter earnings miss, according to the report. The article says investors viewed the repurchase and portfolio transformation as confidence in future performance. Trading volume was 683,126 shares.

International Flavors & Fragrances (NYSE:IFF) reported Q2 CY2026 sales of $1.95 billion, down 29.3% year on year, missing Wall Street expectations. The company lowered full-year revenue guidance to $7.5 billion at the midpoint, about 30.2% below analysts’ estimates. Non-GAAP EPS was $0.82, 26.6% below consensus.